Subtyping social anxiety disorder in developed and developing countries

Depression and Anxiety

Volumn 27, Issue 4, 2010, Pages 390-403

  Stein, Dan J ^a   Ruscio, Ayelet Meron ^b   Lee, Sing ^c   Petukhova, Maria ^d   Alonso, Jordi ^e   Andrade, Laura Helena S G ^f   Benjet, Corina ^g   Bromet, Evelyn ^h   Demyttenaere, Koen ⁱ   Florescu, Silvia ^j   De Girolamo, Giovanni ^k   De Graaf, Ron ^l   Gureje, Oye ^m   He, Yanling ⁿ   Hinkov, Hristo ^o   Hu, Chiyi ^p   Iwata, Noboru ^q   Karam, Elie G ^r   Lepine, Jean Pierre ^s   Matschinger, Herbert ^t   Browne, Mark Oakley ^u   Posada Villa, Jose ^v   Sagar, Rajesh ^w   Williams, David R ^x   Kessler, Ronald C ^d   more..

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d HARVARD MEDICAL SCHOOL   (United States)

^e INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

^g INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^h STONY BROOK UNIVERSITY   (United States)

ⁱ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^j Scoala Nationala de Sanatate Publica si Management Sanitar Bucharest   (Romania)

^k IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^l NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^m UNIVERSITY OF IBADAN   (Nigeria)

ⁿ SHANGHAI MENTAL HEALTH CENTER   (China)

^o National Center of Public Health Protection Bulgaria   (Bulgaria)

^p SHENZHEN KANGNING HOSPITAL   (China)

^q HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

^r UNIVERSITY OF BALAMAND   (Lebanon)

^s ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^t UNIVERSITY OF LEIPZIG   (Germany)

^u UNIVERSITY OF TASMANIA   (Australia)

^v Colombia   (Colombia)

^w ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^x HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

Epidemiology; Social anxiety disorder; Social phobia; Subtype

Indexed keywords

ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEVELOPING COUNTRY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DOSE RESPONSE; FEAR; FEMALE; HEALTH SURVEY; HUMAN; MENTAL HEALTH; OUTCOME ASSESSMENT; PERFORMANCE; POPULATION; PREDICTION; PRIORITY JOURNAL; SOCIAL PHOBIA; WORLD HEALTH ORGANIZATION;

ADULT; AGE OF ONSET; CHRONIC DISEASE; COMMUNITY MENTAL HEALTH SERVICES; COMORBIDITY; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEAR; HEALTH SURVEYS; HOSPITALIZATION; HUMANS; INTERPERSONAL RELATIONS; INTERVIEW, PSYCHOLOGICAL; LIFE CHANGE EVENTS; MIDDLE AGED; PERSONALITY ASSESSMENT; PHOBIC DISORDERS; PSYCHOMETRICS; RISK FACTORS; SOCIAL ENVIRONMENT; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 77953606301     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20639     Document Type: Article

References (41)

1. Magee WJ, Eaton WW, Wittchen HU, McGonagle KA, Kessler RC. Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry 1996;53: 159-168.
2. Ruscio AM, Brown TA, ChiuWT, Sareen J, Stein MB, Kessler RC. Social fears and social phobia in the USA: results from the National Comorbidity Survey Replication. Psychol Med 2008;38:15-28.
3. Fehm L, Pelissolo A, Furmark T,Wittchen HU. Size and burden of social phobia in Europe. Eur Neuropsychopharmacol 2005;15: 453-462.
4. Stein MB, Stein DJ. Social anxiety disorder. Lancet 2008;371: 1115-1125.
5. Weissman MM, Bland RC, Canino GJ, et al. The cross-national epidemiology of social phobia: a preliminary report. Int Clin Psychopharmacol 1996;11:9-14.
6. Muller JE, Koen L, Stein DJ. The spectrum of social anxiety disorders. In: Bandelow B, Stein DJ, editors. Social Anxiety Disorder. New York: Marcel Dekker; 2004.
7. Schneier FR, Blanco C, Antia SX, Liebowitz MR. The social anxiety spectrum. Psychiatr Clin North Am 2002;25:757-774.
8. Chavira DA, Stein MB. The shyness spectrum. CNS Spectr 1999;4:20-29.
9. Heimberg RG, Holt CS, Schneier FR, Spitzer RL, Liebowitz MR. The issue of subtypes in the diagnosis of social phobia. J Anx Disord 1993;7:249-269.
10. Turner SM, Beidel DC, Townsley RM. Social phobia: a comparison of specific and generalized subtypes and avoidant personality disorder. J Abnorm Psychol 1992;101:326-331.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. 4th edition revised. Washington, DC: American Psychiatric Association; 1994.
12. Stein MB, Chartier MJ, Hazen AL, et al. A direct-interview family study of generalized social phobia. Am J Psychiatry 1998;155:90-97.
13. Boone ML, McNeil DW, Masia CL, et al. Multimodal comparisons of social phobia subtypes and avoidant personality disorder. J Anxiety Disord 1999;13:271-292.
14. McTeague LM, Lang PJ, Laplante MC, Cuthbert BN, Strauss CC, Bradley MM. Fearful imagery in social phobia: generalization, comorbidity, and physiological reactivity. Biol Psychiatry 2009;65:374-382.
15. Stein DJ, Ipser JC, van Balkom AJ. Pharmacotherapy for social anxiety disorder. Cochrane Database Syst Rev 2004;CD001206.
16. Furmark T, Tillfors M, Stattin H, Ekselius L, Fredrikson M. Social phobia subtypes in the general population revealed by cluster analysis. Psychol Med 2000;30:1335-1344.
17. Kessler RC, Stein MB, Berglund P. Social phobia subtypes in the National Comorbidity Survey. Am J Psychiatry 1998;155: 613-619.
18. Stein MB, Torgrud LJ, Walker JR. Social phobia symptoms, subtypes, and severity: findings from a community survey. Arch Gen Psychiatry 2000;57:1046-1052.
19. Acarturk C, de Graaf R, van Straten A, Have MT, Cuijpers P. Social phobia and number of social fears, and their association with comorbidity, health-related quality of life and help seeking: a population-based study. Soc Psychiatry Psychiatr Epidemiol 2008;43:273-279.
20. Stein DJ, Kasper S, Andersen EW, Nil R, Lader M. Escitalopram in the treatment of social anxiety disorder: analysis of efficacy for different clinical subgroups and symptom dimensions. Depress Anxiety 2004;20:175-181.
21. Stein DJ, Stein MB, Goodwin W, Kumar R, Hunter B. The selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder. Psychopharmacology (Berl) 2001;158:267-272.
22. Moynihan R, Henry D. The fight against disease mongering: generating knowledge for action. PLoS Med 2006;3:e191.
23. Wakefield JC, Horwitz AV, Schmitz MF. Are we overpathologizing the socially anxious? Social phobia from a harmful dysfunction perspective. Can J Psychiatry 2005;50:317-319.
24. Kessler RC, Haro JM, Heeringa SG, Pennell BE, Ustun TB. The World Health Organization World Mental Health Survey Initiative. Epidemiol Psychiatr Soc 2006;15:161-166.
25. United Nations Development Programme. Human Development Report, 2004. New York: United Nations Development Programme; 2004.
26. Heeringa SG, Wells EJ, Hubbard F, et al. Sample designs and sampling procedures. In: Kessler RC, Üstün TB, editors. The WHOWorld Mental Health Surveys: Global Perspectives on the Epidemiology of Mental Disorders. New York, NY: Cambridge University Press; 2008:14-32.
27. Kessler RC, Ustun TB. The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 2004;13:93-121.
28. Harkness J, Pennell BE, Villar A, Gebler N, Aguilar-Gaxiola S, Bilgen I. Translation procedures and translation assessment in the World Mental Health Survey Initiative. In: Kessler RC, Üstün TB, editors. The WHO World Mental Health Surveys: Global Perspectives on the Epidemiology of Mental Disorders. New York, NY: Cambridge University Press; 2008:91-113.
29. Pennell BE, Mneimneh ZN, Bowers A, et al. Implementation of the World Mental Health Surveys. In: Kessler RC, Üstün TB, editors. The WHO World Mental Health Surveys: Global Perspectives on the Epidemiology of Mental Disorders. New York, NY: Cambridge University Press; 2008:33-57.
30. FirstMB, Spitzer RL, Gibbon M,Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders. New York: New York State Psychiatric Institute, Biometrics Research Department; 1994.
31. Haro JM, Arbabzadeh-Bouchez S, Brugha TS, et al. Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in theWHOWorldMental Health surveys. Int J Methods Psychiatr Res 2006;15:167-180.
32. Green JG, McLaughlin KA, Berglund PA, et al. Childhood adversities and adult psychopathology in the National Comorbidity Survey Replication (NCS-R) I: associations with first onset of DSM-IV disorders. Arch Gen Psychiatry; in press.
33. McLaughlin KA, Green JG, Gruber MJ, Sampson NA, Zaslavsky AM, Kessler RC. Childhood adversities and adult psychopathology in the National Comorbidity Survey Replication (NCS-R) II: associations with persistence of DSM-IV disorders. Arch Gen Psychiatry; in press.
34. Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol 1996;11:89-95.
35. Nock MK, Hwang I, Sampson N, et al. Cross-national analysis of the associations among mental disorders and suicidal behavior: findings from the WHO World Mental Health Surveys. PLoS Med 2009;6:e1000123.
36. Wang PS, Aguilar-Gaxiola S, Alonso J, et al. Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet 2007;370:841-850.
37. Halli SS, Rao VK. Advanced Techniques of Population Analysis. New York: Plenum Press; 1992.
38. Wolter KM. Introduction to Variance Estimation. New York: Springer; 1985.
39. SUDAAN. Professional Software for Survey Data Analysis [computer program]. Research Triangle Park, NC: Research Triangle Institute; 2002.
40. Cox BJ, Clara IP, Sareen J, Stein MB. The structure of feared social situations among individuals with a lifetime diagnosis of social anxiety disorder in two independent nationally representative mental health surveys. Behav Res Ther 2008;46:477-486.
41. Montgomery SA, Lecrubier Y, Baldwin DS, et al. ECNP Consensus Meeting, March 2003. Guidelines for the investigation of efficacy in social anxiety disorder. Eur Neuropsychopharmacology 2004;14:425-433.